AZ, BMS, Lilly, Pfizer make investor's cut

Investor Osman Gulseven finds that of hundreds of healthcare companies listed on the New York Stock Exchange, only four fit his investment objective of  high profitability, substantial dividends and a maximum P/E ratio of 20. Each is a  large-cap drugmaker: AstraZeneca , Bristol-Myers Squibb, Eli Lilly & Co, and Pfizer. Article

Suggested Articles

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

The FDA recently asked five drug manufacturers to recall the commonly used diabetes med metformin. With COVID-19 raging, is metformin just the start?

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.